Aptus Capital Advisors, LLC
- SEC CIK
- 0001664193
- Latest filing
- Aug 12, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Aptus Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 27,966
- Value
- $65.2K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 27,966 | $65.2K | <0.1% | +735+2.7% | Added | Holders |
| Q1 2026 | 27,231 | $59.1K | <0.1% | +621+2.3% | Added | Holders |
| Q4 2025 | 26,610 | $47.9K | <0.1% | +883+3.4% | Added | Holders |
| Q3 2025 | 25,727 | $57.1K | <0.1% | +874+3.5% | Added | Holders |
| Q2 2025 | 24,853 | $36.8K | <0.1% | +915+3.8% | Added | Holders |
| Q1 2025 | 23,938 | $61.3K | <0.1% | +575+2.5% | Added | Holders |
| Q4 2024 | 23,363 | $43.9K | <0.1% | +1,026+4.6% | Added | Holders |
| Q3 2024 | 22,337 | $22.8K | <0.1% | +1,412+6.7% | Added | Holders |
| Q2 2024 | 20,925 | $24.5K | <0.1% | +1,304+6.6% | Added | Holders |
| Q1 2024 | 19,621 | $24.7K | <0.1% | +1,099+5.9% | Added | Holders |
| Q4 2023 | 18,522 | $33.0K | <0.1% | +1,025+5.9% | Added | Holders |
| Q3 2023 | 17,497 | $29.0K | <0.1% | +737+4.4% | Added | Holders |
| Q2 2023 | 16,760 | $33.5K | <0.1% | +750+4.7% | Added | Holders |
| Q1 2023 | 16,010 | $33.6K | <0.1% | +16,010 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −13,957−100.0% | Sold out | Holders |
| Q3 2022 | 13,957 | $15.0K | <0.1% | +1,539+12.4% | Added | Holders |
| Q2 2022 | 12,418 | $14.0K | <0.1% | +967+8.4% | Added | Holders |
| Q1 2022 | 11,451 | $12.0K | <0.1% | +11,451 | New | Holders |